REMI Stock Overview
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Remedent, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.055 |
| 52 Week High | US$0.17 |
| 52 Week Low | US$0.0005 |
| Beta | -0.19 |
| 1 Month Change | -25.68% |
| 3 Month Change | -15.38% |
| 1 Year Change | -67.65% |
| 3 Year Change | -71.05% |
| 5 Year Change | -69.44% |
| Change since IPO | -99.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| REMI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.0% |
| 1Y | -67.6% | -1.4% | 21.9% |
Return vs Industry: REMI underperformed the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: REMI underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| REMI volatility | |
|---|---|
| REMI Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: REMI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine REMI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 3 | Guy De Vreese | www.remedent.com |
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping.
Remedent, Inc. Fundamentals Summary
| REMI fundamental statistics | |
|---|---|
| Market cap | US$1.06m |
| Earnings (TTM) | -US$326.04k |
| Revenue (TTM) | US$49.43k |
21.4x
P/S Ratio-3.3x
P/E RatioIs REMI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| REMI income statement (TTM) | |
|---|---|
| Revenue | €46.11k |
| Cost of Revenue | €27.72k |
| Gross Profit | €18.39k |
| Other Expenses | €322.53k |
| Earnings | -€304.13k |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.016 |
| Gross Margin | 39.89% |
| Net Profit Margin | -659.55% |
| Debt/Equity Ratio | 0% |
How did REMI perform over the long term?
See historical performance and comparison